March 2017: Fibromuscular Dysplasia Awareness Month
WHEREAS, Fibromuscular Dysplasia (FMD) is a disease that causes abnormal cell growth of the arterial wall and can lead to areas of narrowing (stenosis), beading, aneurysms, and dissections (tears) of the arterial wall; and,
WHEREAS, until recently there has been very little progress in understanding the disease since it was first diagnosed in 1938. There is no known cause or cure for the disease and there are no set protocols to treat the disease; and,
WHEREAS, FMD has always been considered and is still classified as a rare disease, and many researchers now believe it is an under-diagnosed disease; and,
WHEREAS, there are different classifications of FMD, with the two most common types being medial fibroplasia and intimal fibroplasia; and,
WHEREAS, the Fibromuscular Dysplasia Society of America (FMDSA) was founded in March of 2003 and has been active and successful with many programs including providing awareness, patient support as well as engaging and working with researchers from around the world; and,
WHEREAS, during the month of March, patients, medical professionals and researchers are joining together to focus attention on Fibromuscular Dysplasia;
NOW, THEREFORE, I, Rick Snyder, governor of Michigan, do hereby proclaim March 2017 as Fibromuscular Dysplasia Awareness Month in Michigan.